Publications by authors named "Lene Vase"

Previous studies of human-dog interventions vary in terms of type of interaction, which is rarely quantified, leading to contradictory findings and limited comparability. To uncover the influence of different types of interactions, the present study investigated if it was possible to detect differences in immediate physiological measurements of healthy humans during different standardised types of interaction with a dog. Thirty-three healthy participants (women = 25, men = 8, >18 years) were exposed to four different test situations with standardised types of interaction intensity with a dog in random order: no dog present (CONTROL), looking at a dog (VISUAL), petting a dog (TACTILE) or performing tricks with a dog (ACTIVE).

View Article and Find Full Text PDF

Mindfulness interventions have been found to lower anxiety. However, the current literature has not adequately considered the role of its individual components and of placebo effects. In an online experiment using a balanced placebo design, we aimed to disentangle effects of decentering, a key component of mindfulness, and expectations, a key component of placebo effects, on anxiety related to the COVID-19 pandemic.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare the effects of two types of conversations—an illness perception conversation (IPC) and a research participation conversation (RPC)—on changes in knee pain over two weeks in patients with knee osteoarthritis.
  • It was a randomized trial where patients had either IPC or RPC conversations, followed by a saline injection in their most painful knee; the primary outcome measured was the change in knee pain using a visual analogue scale.
  • Results showed both groups experienced a similar decrease in pain, indicating that the IPC did not provide any additional pain relief compared to the RPC, with no significant differences in quality of life or daily living activities.
View Article and Find Full Text PDF

Objective: Expectations are highlighted as a key component in placebo effects. However, there are different approaches to whether and how placebo studies should account for expectations, and the direct contribution has yet to be estimated in meta-analyses. Using different methodological approaches, this meta-analysis and systematic review examines the extent to which expectations contribute to pain in placebo studies.

View Article and Find Full Text PDF

Background: With evidence for large nocebo effects in pain, guidelines for nocebo-minimizing strategies regarding side effect disclosure are emerging. While the ethical implications and effectiveness of such strategies have been the subject of investigations, the perspective of healthcare users are missing despite the stakes for patient autonomy.

Methods: In an online survey, 2766 adults (≥18 years) from a general population sample in Europe and North America responded to questions related to nocebo familiarity, nocebo beliefs and attitudes towards side effect disclosure.

View Article and Find Full Text PDF

Background: Multisystem functional somatic disorder is characterized by specific patterns of persistent physical symptoms with a complex biopsychosocial etiology. The disorder can lead to disability and personal suffering. Current treatment options require specialized settings, therefore patients often wait a long time to receive specific treatment.

View Article and Find Full Text PDF

Background And Objectives: In Parkinson's disease (PD) patients, verbal suggestions have been shown to modulate motor and clinical outcomes in treatment with subthalamic deep brain stimulation (DBS). Furthermore, DBS may alleviate pain in PD. However, it is unknown if verbal suggestions influence DBS' effects on pain.

View Article and Find Full Text PDF

Background: The magnitude of placebo effects from physical and psychological 'sham' is unknown but could impact efficacy trials and treatment understanding. To quantify placebo effects, this systematic review of three-armed randomised controlled trials (RCTs) of physical and psychological interventions for pain compared outcomes in 'sham' control intervention and non-exposure arms.

Methods: RCTs with treatment, 'sham' control intervention, and non-exposure groups were included, enrolling adults with any pain.

View Article and Find Full Text PDF

Informing patients about potential side effects of pain treatment is a requirement that protects patients and aids decision making, but it increases the likelihood of unwanted nocebo side effects. If patients do not desire all side-effect information, it may be possible to ethically reduce nocebo effects through authorized concealment of side effects, whereby patients and clinicians engage in shared decision-making to regulate the disclosure of side-effect information. Currently, there is no experimental data clarifying the factors that causally influence desire for side-effect information in pain treatment.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the impact of placebo analgesia (pain relief) and nocebo hyperalgesia (pain increase) in patients with mild-to-moderate Alzheimer's disease (AD), which is not well understood.
  • Twenty-one AD patients and 26 healthy participants were exposed to thermal pain under different conditions involving lidocaine and capsaicin, with verbal suggestions to influence pain perception.
  • Results showed that healthy participants experienced placebo effects, while AD patients did not show significant placebo or nocebo effects, suggesting that AD might limit these phenomena, which is important for clinical trial design and treatment approaches.
View Article and Find Full Text PDF

(1) Background: In recent years, placebo and nocebo effects have been extensively documented in different medical conditions, including pain. The scientific literature has provided strong evidence of how the psychosocial context accompanying the treatment administration can influence the therapeutic outcome positively (placebo effects) or negatively (nocebo effects). (2) Methods: This state-of-the-art paper aims to provide an updated overview of placebo and nocebo effects on pain.

View Article and Find Full Text PDF

Indirect treatment comparisons (ITCs) are anchored on a placebo comparator, and the placebo response may vary according to drug administration route. Migraine preventive treatment studies were used to evaluate ITCs and determine whether mode of administration influences placebo response and the overall study findings. Change from baseline in monthly migraine days produced by monoclonal antibody treatments (subcutaneous, intravenous) was compared using fixed-effects Bayesian network meta-analysis (NMA), network meta-regression (NMR), and unanchored simulated treatment comparison (STC).

View Article and Find Full Text PDF
Article Synopsis
  • Infections have historically been the leading cause of illness and death, with pain serving as a key symptom, yet pain may persist even after infections resolve.
  • Chronic pain following infections can take various forms, including neuropathic, nociplastic, and nociceptive pain, influenced by mechanisms like immune responses and direct microbe effects.
  • Certain bacteria and viruses are linked to chronic pain, but while antimicrobial treatments can sometimes help, they may be more harmful than beneficial in cases where pain is tied to autoimmune issues or central sensitization.
View Article and Find Full Text PDF

Background: The nocebo response refers to the phenomenon where non-specific factors, including negative verbal suggestion and treatment expectations, cause adverse events (AE) following a placebo treatment. Non-specific factors are also likely to influence AE occurrence following administration of active pharmacological treatments.

Objective: This meta-analysis aimed to estimate the nocebo response in dentistry by assessing the AEs prevalence in placebo- and active arms of randomised controlled trials (RCTs) assessing analgesic treatment following third molar (M3) surgery.

View Article and Find Full Text PDF
Article Synopsis
  • Cannabinoids like CBD and THC are commonly prescribed for neuropathic pain, but existing evidence suggests they may not be effective.
  • A study tested the effects of CBD, THC, their combination, and a placebo on patients with various types of neuropathic pain over 8 weeks, but none of the treatments significantly reduced pain compared to the placebo.
  • The trial included 145 patients, and results showed no meaningful pain relief from any treatment, leading to the conclusion that cannabinoids are not effective for this condition in patients who have already tried other treatments.
View Article and Find Full Text PDF
Article Synopsis
  • Negative beliefs about vaccine side-effects can spread through social communications, impacting expectations and experiences related to COVID-19 vaccination side-effects.
  • A study involving 551 participants found that pre-vaccination social media views and personal accounts influenced both expectations of side-effects and the actual experiences of side-effects after vaccination.
  • The findings suggest that managing expectations through social channels could potentially alter side-effect experiences for COVID-19 and other vaccines.
View Article and Find Full Text PDF

Introduction: While the placebo effect is increasingly recognised as a contributor to treatment effects in clinical practice, the nocebo and other undesirable effects are less well explored and likely underestimated. In the chiropractic, osteopathy and physiotherapy professions, some aspects of historical models of care may arguably increase the risk of nocebo effects.

Purpose: In this masterclass article, clinicians, researchers, and educators are invited to reflect on such possibilities, in an attempt to stimulate research and raise awareness for the mitigation of such undesirable effects.

View Article and Find Full Text PDF

Introduction: Placebo-controlled surgical designs are recommended to ascertain treatment effects for elective surgeries when there is genuine doubt about the effectiveness of the surgery. Some elective surgeries for pain have been unable to show an effect beyond sham surgery, suggesting contributions from contextual factors. However, the nature of contextual factors in elective surgery is largely unexplored.

View Article and Find Full Text PDF

Sham interventions in randomized clinical trials (RCTs) of physical, psychological, and self-management (PPS) therapies for pain are highly variable in design and believed to contribute to poor internal validity. However, it has not been formally tested whether the extent to which sham controls resemble the treatment under investigation consistently affects trial outcomes, such as effect sizes, differential attrition, participant expectancy, and blinding effectiveness. Placebo- or sham-controlled RCTs of PPS interventions of clinical pain populations were searched in 12 databases.

View Article and Find Full Text PDF
Article Synopsis
  • Blinding in randomized controlled trials for pain therapies is difficult due to the complex and interactive nature of these treatments, necessitating a review of current sham interventions and blinding methods.
  • A systematic search of twelve databases identified 198 unique control interventions from clinical trials published between 2008 and December 2021, primarily focusing on patients with chronic pain, especially in manual therapies.
  • The study highlighted varying degrees of similarity between active and control treatments, and provided insights into improving blinding methods and reporting practices for future trials.
View Article and Find Full Text PDF

In placebo research, expectations are highlighted as one of the most influential subjective factors. While some studies have shown a relationship between expectations and pain relief, others have not. However, little is known about how methods of assessment of expectations may affect these conclusions.

View Article and Find Full Text PDF

Around 20% of the adult population experience chronic pain. Non-pharmacological pain treatments have shown promising effects. Yet, contrary to pharmacological trials, there are no standardised methods for evaluating the effect of non-pharmacological treatments.

View Article and Find Full Text PDF